Achieve Life Sciences, Inc. (ACHV) Operating cash flow 2016–2025
Achieve Life Sciences, Inc. (ACHV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$49.5MFY2025 · since FY2016: -$202,000 → -$49.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.5M | -66.2% |
| FY2024 | -$29.8M | -21.6% |
| FY2023 | -$24.5M | +34.8% |
| FY2022 | -$37.6M | -27.6% |
| FY2021 | -$29.4M | -118.5% |
| FY2020 | -$13.5M | +11.4% |
| FY2019 | -$15.2M | -43.2% |
| FY2018 | -$10.6M | -16.6% |
| FY2017 | -$9.1M | -4408.4% |
| FY2016 | -$202,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACHV financial trends
ACHV RevenueACHV Net incomeACHV Net marginACHV Gross profitACHV Gross marginACHV Operating incomeACHV Operating marginACHV Free cash flowACHV Capital expendituresACHV Return on equityACHV Stock buybacksACHV Dividends paidACHV Total assetsACHV Total liabilitiesACHV Shareholders’ equityACHV overview →